Serum albumin and white matter hyperintensities

Natalie M. Zahr,Adolf Pfefferbaum

DOI: https://doi.org/10.1038/s41398-024-02953-5

2024-06-02

Translational Psychiatry

Abstract:People living with HIV and those diagnosed with alcohol use disorders (AUD) relative to healthy individuals commonly have low levels of serum albumin, substantiated as an independent predictor of cardiovascular events. White matter hyperintensities (WMH)—a neuroimaging feature of cerebral small vessel disease—are also related to cardiovascular disease. Despite consensus regarding associations between high levels of urine albumin and WMH prevalence, and low serum albumin levels and impaired cognitive functioning, relations between serum albumin and WMH burdens have rarely been evaluated. Here, a sample including 160 individuals with AUD, 142 living with HIV, and 102 healthy controls was used to test the hypothesis that serum albumin would be inversely related to WMH volumes and directly related to cognitive performance in the two diagnostic groups. Although serum albumin and periventricular WMH volumes showed an inverse relationship in both AUD and HIV groups, this relationship persisted only in the HIV group after consideration of traditional cardiovascular (i.e., age, sex, body mass index (BMI), nicotine use, hypertension, diabetes), study-relevant (i.e., race, socioeconomic status, hepatitis C virus status), and disease-specific (i.e., CD4 nadir, HIV viral load, HIV duration) factors. Further, serum albumin contributed more significantly than periventricular WMH volume to variance in performance on a verbal learning and memory composite score in the HIV group only. Relations in both HIV and AUD groups between albumin and hematological red blood cell markers (e.g., hemoglobin, hematocrit) suggest that in this sample, serum albumin reflects hematological abnormalities. Albumin, a simple serum biomarker available in most clinical settings, may therefore help identify periventricular WMH burden and performance levels in specific cognitive domains in people living with HIV. Whether serum albumin contributes mechanistically to periventricular WMH in HIV will require additional investigation.

psychiatry

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore whether low serum albumin levels are associated with increased white matter hyperintensity (WMH) volume and cognitive decline, especially in individuals with alcohol use disorder (AUD) and human immunodeficiency virus (HIV) infection. The research background indicates that low serum albumin levels are common in HIV - infected individuals and AUD patients and have been proven to be an independent predictor of cardiovascular events. Meanwhile, white matter hyperintensity (WMH), as a neuroimaging feature of cerebral small - vessel disease, is also related to cardiovascular diseases. Although previous studies have shown that urinary albumin levels are associated with a high incidence of WMH and that low serum albumin levels are associated with impaired cognitive function, research on the relationship between serum albumin and WMH burden is rare. Specifically, the study hypothesized that serum albumin levels are negatively correlated with WMH volume and positively correlated with cognitive performance, especially in the two diagnostic groups of AUD and HIV. The study tested this hypothesis by analyzing sample data including 160 AUD patients, 142 HIV - infected individuals, and 102 healthy controls. The study results showed that after considering traditional cardiovascular risk factors (such as age, sex, body mass index, nicotine use, hypertension, diabetes), study - related variables (such as race, socioeconomic status, hepatitis C virus infection status), and disease - specific variables (such as CD4 nadir, HIV viral load, HIV duration), this relationship persisted only in the HIV group. In addition, serum albumin contributed more to the variability of the verbal learning and memory composite score in the HIV group than WMH volume. These findings suggest that serum albumin may be helpful in identifying the WMH burden and performance levels in specific cognitive domains in HIV - infected individuals.

Serum albumin and white matter hyperintensities

Age-Accelerated Increase of White Matter Hyperintensity Volumes Is Exacerbated by Heavy Alcohol Use in People Living With HIV

Associations of Serum Albumin with Disability in Activities of Daily Living, Mobility and Objective Physical Functioning Regardless of Vitamin D: Cross-Sectional Findings from the Chinese Longitudinal Healthy Longevity Survey.

Whole-brain N-acetylaspartate level and cognitive performance in HIV infection

Neuropsychological Performance Is Positively Associated with Plasma Albumin in Healthy Adults

Plasma biomarkers of vascular dysfunction uniquely relate to a vascular-risk profile of neurocognitive deficits in virally-suppressed adults with HIV

Aging, HIV infection, and alcohol exert synergist effects on regional thalamic volumes resulting in functional impairment

Sex and race differences in the association of albumin with cognitive function in older adults

Elevated homocysteine levels may moderate and mediate the association between HIV and cognitive impairment among middle-aged and older adults in an underserved population in Baltimore, Maryland

Association between admission serum albumin and 12-weeks mortality in patients with late AIDS/HIV diagnosis: a retrospective cohort study

Alcohol consumption and neurocognitive deficits in people with well-treated HIV in Switzerland

Serum Prealbumin Levels and Risks of Adverse Clinical Outcomes after Ischemic Stroke

Association between Body Mass Index or Serum Albumin and Different Dementia Populations

Relationships between plasma neurofilament light chain protein, cognition, and brain aging in people with HIV

Relative sensitivity of magnetic resonance spectroscopy and quantitative magnetic resonance imaging to cognitive function among nondemented individuals infected with HIV

Serum Mature and Precursor Brain-Derived Neurotrophic Factors and Their Association with Neurocognitive Function in ART-Naïve Adults Living with HIV in Sub-Saharan Africa

CD14+CD16+ monocyte transmigration across the blood-brain barrier is associated with HIV-NCI despite viral suppression

Cardiovascular Disease, Brain Glucose Metabolism, and Neurocognitive Decline in People With Human Immunodeficiency Virus

White and Gray Matter Changes are Associated With Neurocognitive Decline in HIV Infection

Brain Volumetric Alterations in Preclinical HIV-Associated Neurocognitive Disorder Using Automatic Brain Quantification and Segmentation Tool

Association of hemoglobin with plasma neurofilament light and white matter hyperintensities in Alzheimer's disease continuum